CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Harbin Pharmaceutical Group Company Limited Company Snapshot
Harbin Pharmaceutical Group Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Harbin Pharmaceutical Group Company Limited with three other companies in this sector in China: Shanghai Fosun Pharmaceutical (Group) Company Limited (2016 sales of 14.51 billion Chinese Renmimbi [US$2.15 billion] of which 70% was Pharmaceutical Manufacturing and R&D), Shenzhen Neptunus Bioengineer (13.61 billion Chinese Renmimbi [US$2.02 billion] of which 84% was Pharmaceutical Distribution), and Tasly Pharmaceutical Group Company Limited (13.95 billion Chinese Renmimbi [US$2.07 billion] of which 51% was Medicine Commerce).

Sales Analysis. Harbin Pharmaceutical Group Company Limited reported sales of 14.13 billion Chinese Renmimbi (US$2.09 billion) for the year ending December of 2016. This represents a decrease of 10.9% versus 2015, when the company's sales were 15.85 billion Chinese Renmimbi. The sales level in 2016 was fairly close to the level five years ago: in 2011, Harbin Pharmaceutical Group Company Limited had sales of 13.47 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 42.4% decline in Other Operating, from 74.48 million Chinese Renmimbi to 42.87 million Chinese Renmimbi. There were also decreases in sales in Medicine Trade (down 7.1% to 8.98 billion Chinese Renmimbi) and Medicine Industry (down 15.5% to 5.10 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Harbin Pharmaceutical Group Company Limited
  Stock Performance Chart for Harbin Pharmaceutical Group Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): 5.73
(Figures in Chinese Renmimbi)
1 Week -2.4%   13 Weeks -1.2%  
4 Weeks -20.5%   52 Weeks -32.3%  
 
Harbin Pharmaceutical Group Company Limited Key Data:
  Ticker: 600664 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 14,126,376,450
(Year Ending Jan 2017).
Employees: 16,949
  Currency: Chinese Renmimbi Market Cap: 14,283,333,021
  Fiscal Yr Ends: December Shares Outstanding: 2,492,728,276
  Share Type: A Gu Closely Held Shares: 1,360,184,310
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.